Pseudophakic ametropia management with toric implantable col
To report the clinical outcomes of correcting pseudophakic ametropia using toric implantable collamer lens with a 360 um central hole (TICL V4c).

Case presentation
The right eye of a 22-year-old male patient developed high myopia after unilateral phacoemulsification and intraocular lens (IOL) implantation following traumatic cataract 16 years ago. The manifest refraction was -11.50 DS/-2.50 DC?×?175 with an uncorrected distance visual acuity (UDVA) of 20/2000 and a corrected distance visual acuity (CDVA) of 20/20. The manifest refraction of left eye was -6.25 DS/-3.75 DC?×?180 with UDVA 20/200 and CDVA 20/20. Both eyes were implanted posterior chamber TICL V4c lens. Postoperatively, the refractive errors were +1.00 DS/-0.50 DC?×?50 with UDVA 20/16 and CDVA 20/16 in the right eye and +0.75 DS/-0.75 DC?×?45 with UDVA 20/16 and CDVA 20/13 in the left eye, respectively. No complications were observed.

TICL V4c is safe, effective and predictable in managing pseudophakic ametropia.